Haemonetics Corporation (HAE) Gains on Strong Plasma Growth and Higher Guidance, Ariel Appreciation Fund Says
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- HAE Haemonetics+12.9% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Haemonetics belongs to, so it often moves with news about it.
- SYK Stryker+13.4% 30d
Stryker is a peer of Haemonetics in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+4.2% 30d
3M is a peer of Haemonetics in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific-1.7% 30d
Boston Scientific is a peer of Haemonetics in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+9.7% 30d
Becton, Dickinson and is a peer of Haemonetics in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline-12.6% 11d
Medline is a peer of Haemonetics in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| HAE | -2.56% | -1.09% | base | -1.42% | -0.04% | -0.59% | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| SYKNo price data for this ticker | — | — | — | — | — | — | — |
| MMMNo price data for this ticker | — | — | — | — | — | — | — |
| BSXNo price data for this ticker | — | — | — | — | — | — | — |
| BDXNo price data for this ticker | — | — | — | — | — | — | — |
| MDLNNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Haemonetics Corporation (HAE) Gains on Strong Plasma Growth and Higher Guidance, Ariel Appreciation Fund Says Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| HAE | that day | -1.42% | final price |
| HAE | the next day | -0.04% | final price |
| HAE | two days later | -0.59% | still updating |
| HAE | three days earlier | -1.09% | final price |
| HAE | five days earlier | -2.56% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 49 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 54 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 55 days before publication. Filed 25 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, bought Becton Dickinson (BDX), worth $100,001 - $250,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100Price not final
“Haemonetics Corporation (HAE) Gains on Strong Plasma Growth and Higher Guidance, Ariel Appreciation Fund Says” scores 12 out of 100. The score uses 1 sources. The price is not final yet.